Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Oktober 2024

Genmab — Oktober 2024

Planlagt Fastgjort Låst Flyttet Genmab
991 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #103

    Godmorgen 🙂

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Stroka
      wrote on sidst redigeret af
      #104

      God morgen 🙂

      1 Reply Last reply
      0
      • L Offline
        L Offline
        LP90
        wrote on sidst redigeret af
        #105

        Godmorgen 🙂

        1 Reply Last reply
        0
        • StockBullS Offline
          StockBullS Offline
          StockBull
          wrote on sidst redigeret af
          #106

          Godmorgen 🙂

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #107

            Der kan også være fonde m.m., der har stop-loss på deres Genmab-aktier. Uanset hvor gode nyhederne måtte være, er de måske nødt til at overholde deres stop-loss-regler. Jeg formoder, at de har regler, de skal følge, og de kan ikke bare sidde og se på, at en aktie falder 50% uden at handle. Dette kan muligvis være med til at forstærke nedturen.

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #108

              Opdivo wins FDA label expansion in perioperative NSCLC https://firstwordpharma.com/story/5901073

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #109

                Have we been given any information yet as to whether genmab is allowed to develop an antibody targeting EGFR and cMET (PRO1286) within the rules of the contract they have with JNJ on amivantamab?

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #110

                  I would guess they can but not sure. In the Duobody agreement the partner pays a smaller amount in the beginning of a program and gets exclusivity for a shorter period of time. My understanding hereafter that others could persue same target combination. Zymeworks for instance had no exclusivity on their BsAb platform

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #111

                    Since Genmab have deeper knowledge on Amivantamab arms there could be other rules applied here.

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #112

                      ok, thanks. I am pondering the fact that they are starting a clinical trial in China. i was even thinking, if China could fall outside of the reach of an agreement, they could give prove of concept there and then sell the product

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #113

                        curious if we will hear more about this in their quarterly reporting

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #114

                          similar thoughts/doubts
                          Sukkeralf https://x.com/JacobPlieth/status/1842115371467219052

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #115

                            we could even end up with a similar deal with JNJ as Hexa-CD38 with Dara, but i very much doubt Jan is very keen on that atm...

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              Journalisten
                              wrote on sidst redigeret af
                              #116

                              Tak for svar og lidt som ventet, - at der tilsyneladende aldrig har været seriøse rygter om Genmab som opkøbsmål, - bortset altså tilbage i 2009.

                              1 Reply Last reply
                              0
                              • J Offline
                                J Offline
                                JKY_VH
                                wrote on sidst redigeret af
                                #117

                                Jeg synes, at du skal skrive en artikel om, at opkøbsrygterne tager til;-)

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #118

                                  Well,
                                  that is not completely true @Journalisten ; there have been enough rumours over the years for Jan to make public statements about it, that he wanted to stay independent and that the best way to do that would be to keep the share price as high as possible. He did that more then once.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #119

                                    and the rumours were not without base. JNJ had a very sizable share position in Genmab already at the time. And looking back, if JNJ had chosen for a take-over instead of selling that position they would have made an amazing deal if you put it against all the royalties they are paying now

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #120

                                      Det afhænger nok af, hvordan man definerer seriøse rygter. Der har været mange rygter samt analytikere, der har argumenteret for mulige opkøb, men indtil videre har der ikke været noget konkret bud. Vi ved ikke, hvad der er foregået bag lukkede døre, men det ser ud til, at Jan har afvist flere tilbud, da han gentagne gange har understreget, at Genmab ikke er til salg.

                                      1 Reply Last reply
                                      0
                                      • StockBullS Offline
                                        StockBullS Offline
                                        StockBull
                                        wrote on sidst redigeret af
                                        #121

                                        nogle konkrete officielle bud

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          gentogen
                                          wrote on sidst redigeret af
                                          #122

                                          Mig bekendt har ingen i denne chat lanceret rygter om opkøb, men blot præsenteret fornuftige argumenter for, hvorfor dette eller hint selskab måtte kunne have en interesse i Genmab. Det kan undertiden være lidt spekulativt, men det er ikke rygter

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper